Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canadian Cannabis was a Canadian medical cannabis company that operated through its wholly owned subsidiary, Canada Cannabis Corp. The business was focused on cultivating, marketing, and manufacturing medical marijuana products for sale in Canada, with plans to offer multiple dried cannabis strains as well as inputs for edible and elixir formulations. The company was publicly traded in the United States under the symbol CCAN on the OTC market. Available sources indicate the company is now permanently closed, and there is no evidence of an active operating business today. Its historical positioning was as an early-stage medical cannabis developer rather than a traditional biotech or pharmaceutical drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canadian Cannabis.